Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms.
Vigh T, Démuth B, Balogh A, Galata DL, Van Assche I, Mackie C, Vialpando M, Van Hove B, Psathas P, Borbás E, Pataki H, Boeykens P, Marosi G, Verreck G, Nagy ZK.
Vigh T, et al. Among authors: pataki h.
Drug Dev Ind Pharm. 2017 Jul;43(7):1126-1133. doi: 10.1080/03639045.2017.1298121. Epub 2017 Mar 8.
Drug Dev Ind Pharm. 2017.
PMID: 28274133